APGE — Apogee Therapeutics, Inc. stock price, charts and financials

QT91Apogee Therapeutics, Inc.

Apogee Therapeutics, Inc. (NASDAQ: APGE) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
135.07
-0.01-0.01%
OverviewShort InterestFilings
APGEQT91Apogee Therapeutics, Inc.·NASDAQ
135.07-0.01%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Sep 14, 202615-12G15-12G
Sep 08, 2026SC 13D/ABeneficial ownership statement (active, amended)
Sep 03, 2026S-8 POSS-8 POS
Sep 03, 20264Statement of changes in beneficial ownership
Sep 03, 20264Statement of changes in beneficial ownership
Sep 03, 202625-NSENotification of removal from listing
Sep 03, 2026S-8 POSS-8 POS
Sep 03, 2026SC 13D/ABeneficial ownership statement (active, amended)
Sep 03, 2026S-8 POSS-8 POS
Sep 03, 20268-KCurrent report
Sep 03, 2026POSASRPOSASR
Sep 03, 20264Statement of changes in beneficial ownership
Sep 03, 2026S-8 POSS-8 POS
Sep 03, 20264Statement of changes in beneficial ownership
Sep 03, 20264Statement of changes in beneficial ownership
Sep 03, 20264Statement of changes in beneficial ownership
Sep 03, 20264Statement of changes in beneficial ownership
Sep 03, 2026S-8 POSS-8 POS
Sep 03, 20264Statement of changes in beneficial ownership
Sep 03, 20264Statement of changes in beneficial ownership
Aug 11, 20264Statement of changes in beneficial ownership
Aug 11, 20268-KCurrent report
Aug 10, 202610-QQuarterly report
Aug 10, 20268-KCurrent report
Aug 07, 20264Statement of changes in beneficial ownership
#1 / 25 of 315
Page
▼
/ 13